Clusters of differentiation 24 polymorphism and hepatocellular carcinoma

Hepatology

Volumn 54, Issue 6, 2011, Pages 2274-2275

  Sheng, Liming ^a   Shui, Yongjie ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; ANTINEOPLASTIC AGENT; CD24 ANTIGEN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS C VIRUS; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; IMMUNOMODULATION; INFECTION RISK; LETTER; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG CANCER; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR MICROENVIRONMENT;

EID: 82455162596     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24676     Document Type: Letter

References (3)

1. Li D, Zheng L, Jin L, Zhou Y, Li H, Fu J, et al. CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection. Hepatology 2009; 50: 735-742.
2. Gu X, Qi P, Zhou F, Ji Q, Wang H, Dou T, et al. An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population. Hum Genet 2010; 127: 75-81.
3. Young R, Hopkins R, Etzel C, El-Zein R. Genetics of lung cancer susceptibility and COPD. Lancet Oncol 2011; 12: 622-623.